Albemarle Corporation Website

Albemarle Corporation

NYSE-ALB

Basic

  • Market Cap

    $11.03B

  • EV

    $15.14B

  • Shares Out

    117.53M

  • Revenue

    $8,397.69M

  • Employees

    9,000

Margins

  • Gross

    -0.48%

  • EBITDA

    -3.78%

  • Operating

    -9.33%

  • Pre-Tax

    6.67%

  • Net

    4.02%

  • FCF

    -19.18%

Returns (5Yr Avg)

  • ROA

    8.59%

  • ROTA

    17.83%

  • ROE

    16.87%

  • ROCE

    10.93%

  • ROIC

    9.81%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $135.75

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $2,055.81M

  • Net Debt

    $1,612.06M

  • Debt/Equity

    0.31

  • EBIT/Interest

    -6.16

Growth (CAGR)

  • Rev 3Yr

    37.66%

  • Rev 5Yr

    19.93%

  • Rev 10Yr

    13.31%

  • Dil EPS 3Yr

    -6.19%

  • Dil EPS 5Yr

    -15.55%

  • Dil EPS 10Yr

    -5.17%

  • Rev Fwd 2Yr

    -15.15%

  • EBITDA Fwd 2Yr

    -28.23%

  • EPS Fwd 2Yr

    -49.89%

  • EPS LT Growth Est

    -19.91%

Dividends

  • Yield

  • Payout

    57.65%

  • DPS

    $1.6

  • DPS Growth 3Yr

    1.17%

  • DPS Growth 5Yr

    3.11%

  • DPS Growth 10Yr

    4.86%

  • DPS Growth Fwd 2Yr

    1.91%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

3,589.4

3,128.9

3,328

7,320.1

9,617.2

8,397.7

Total Revenues % Chg.

6.4%

-12.8%

6.4%

120%

31.4%

-4.3%

Cost of Goods Sold, Total

2,330.9

2,132.1

2,319.5

4,242.3

8,420.3

8,438.4

Gross Profit

1,258.5

996.9

1,008.5

3,077.8

1,196.9

-40.7

Selling General & Admin Expenses, Total

470.4

427.2

333.3

439.1

644.1

654

R&D Expenses

58.3

59.2

54

72

85.7

88.8

Other Operating Expenses, Total

528.7

486.4

387.3

511.1

729.8

742.8

Operating Income

729.8

510.5

621.1

2,566.7

467.1

-783.5

Interest Expense, Total

-52.9

-73.1

-32.5

-103.8

-116.1

-127.3

Interest And Investment Income

19.3

19.3

Net Interest Expenses

-52.9

-73.1

-32.5

-103.8

-96.8

-108

Income (Loss) On Equity Invest.

129.6

127.5

95.8

772.3

1,854.1

1,638.4

Currency Exchange Gains (Loss)

-27.4

-28.8

0.1

-21.8

39.9

16.8

Other Non Operating Income (Expenses)

15.5

6.6

14.7

44.5

80.3

129.5

EBT, Excl. Unusual Items

794.6

542.7

699.1

3,257.9

2,344.6

893.3

Restructuring Charges

-19.9

-3.2

-4.3

-11.8

-47.4

Merger & Related Restructuring Charges

-20.7

-17.3

-12.7

-16.3

-26.8

-23.6

Impairment of Goodwill

-6.8

-6.8

Gain (Loss) On Sale Of Investments

7.2

4.3

-39.2

-119.4

Gain (Loss) On Sale Of Assets

11.1

3.6

296

-8.4

71.2

90.9

Asset Writedown

Insurance Settlements

7.3

7.3

Legal Settlements

1.2

-667.9

0.1

-233.6

-233.7

Other Unusual Items

-92.5

-16.5

-81.9

-27.6

-4.1

-0.5

EBT, Incl. Unusual Items

692.5

501

229.4

3,205.7

2,100.8

560.1

Income Tax Expense

88.2

54.4

29.4

390.6

430.3

149.6

Earnings From Continuing Operations

604.4

446.6

199.9

2,815.1

1,670.5

410.5

Earnings Of Discontinued Operations

Minority Interest

-71.1

-70.9

-76.3

-125.3

-97.1

-73.1

Net Income

533.2

375.8

123.7

2,689.8

1,573.5

337.3

Preferred Dividend and Other Adjustments

11.6

Net Income to Common Incl Extra Items

533.2

375.8

123.7

2,689.8

1,573.5

325.8

Net Income to Common Excl. Extra Items

533.2

375.8

123.7

2,689.8

1,573.5

325.8

Total Shares Outstanding

106

106.8

117

117.2

117.4

117.5

Weighted Avg. Shares Outstanding

105.9

106.4

115.8

117.1

117.3

117.4

Weighted Avg. Shares Outstanding Dil

106.3

106.8

116.5

117.8

117.8

117.7

EPS

5

3.5

1.1

23

13.4

2.8

EPS Diluted

5

3.5

1.1

22.8

13.4

2.8

EBITDA

943.3

742.5

875.1

2,867.5

897.1

-317.1

Effective Tax Rate

12.7%

10.9%

12.8%

12.2%

20.5%

26.7%